COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,556 Articles (22,400 medRxiv, 8,156 bioRxiv)

Most recent first Previous |  Page 2541: Articles 25401-25410  | Next

Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early prognostic marker for severe COVID-19
Carissimo, G., Xu, W., Kwok, I., Abdad, M. Y., Chan, Y. H., Fong, S. W., Puan, K. J., Lee, C. Y. P., Yeo, N. K.-W., Amrun, S. N., Chee, R. S.-L., How, W., Chan, S., Fan, E. B., Andiappan, A., Lee, B., Rotzschke, O., Young, B. E., Leo, Y.-S., Lye, D. C., Renia, L., Ng, L. G., Larbi, A., Ng, L. F.
10.1101/2020.06.11.147389 — Posted: 2020-06-12 Discussion: Onsite | Offsite
Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate
Iserman, C., Roden, C. A., Boerneke, M., Sealfon, R., McLaughlin, G., Jungreis, I., Park, C. Y., Boppana, A., Fritch, E., Hou, Y., Theesfeld, C., Troyanskaya, O., Baric, R. S. G., Sheahan, T. P., Weeks, K., Gladfelter, A.
10.1101/2020.06.11.147199 — Posted: 2020-06-12 Discussion: Onsite | Offsite
Machine Learning Maps Research Needs in COVID-19 Literature
Doanvo, A. L., Qian, X., Ramjee, D., Piontkivska, H., Desai, A. N., Majumder, M. S.
10.1101/2020.06.11.145425 — Posted: 2020-06-12 Discussion: Onsite
Highly sensitive and specific multiplex antibody assays to quantify immunoglobulins M, A and G against SARS-CoV-2 antigens
Dobano, C., Vidal, M., Santano, R., Jimenez, A., Chi, J., Barrios, D., Ruiz-Olalla, G., Rodrigo Melero, N., Carolis, C., Parras, D., Serra, P., Martinez de Aguirre, P., Carmona-Torre, F., Reina, G., Santamaria, P., Mayor, A., Alberto Garcia-Basteiro, A., Izquierdo, L., Aguilar, R., Moncunill, G.
10.1101/2020.06.11.147363 — Posted: 2020-06-12 Discussion: Onsite | Offsite
Hidden in plain sight: The effects of BCG vaccination in COVID-19 pandemic
Toriah, E. A., Sedhom, J. A., Dokunmu, T. M., Hussein, M. H., Ruiz, E. M., Muthusamy, K., Zerfaoui, M., Kandil, E.
10.1101/2020.06.09.142760 — Posted: 2020-06-12
Evolution and epidemic spread of SARS-CoV-2 in Brazil
Candido, D. d. S., Claro, I. M., de Jesus, J. G., Souza, W. M. d., Moreira, F. R. R., Dellicour, S., Mellan, T. A., du Plessis, L., Pereira, R. H. M., Sales, F. C. d. S., Manuli, E. R., Theze, J., Almeida, L., de Menezes, M. T., Voloch, C. M., Fumagalli, M. J., Coletti, T. d. M., Silva, C. A. M., Ramundo, M. S., Amorim, M. R., Hoeltgebaum, H., Mishra, S., Gill, M., Carvalho, L. M., Buss, L. F., Prete, C. A., Ashworth, J., Nakaya, H., Peixoto, P. d. S., Brady, O. J., Nicholls, S. M., Tanuri, A., Rossi, A. D., Braga, C. K. V., Gerber, A. L., Guimaraes, A. P., Gaburo, N., Alencar, C. S., Ferreira, A. C. d. S., Lima, C. X., Levi, J. E., Granato, C., Ferreira, G. M., Francisco, R. d. S., Granja, F., Garcia, M. T., Moretti, M. L., Perroud, M. W., Castineiras, T. M. P. P., Lazari, C. D. S., Hill, S. C., Santos, A. A. d. S., Simeoni, C. L., Forato, J., Sposito, A. C., Schreiber, A. Z., Santos, M. N. N., Sa, C. Z., Souza, R. P., Resende Moreira, L. C., Teixeira, M. M., Hubner, J., Leme, P. A. F., Moreira, R. G., Nogueira, M. L., Ferguson, N., Costa, S. F., Proenca-Modena, J. L., Vasconcelos, A. T., Bhatt, S., Lemey, P., Wu, C.-H., Rambaut, A., Loman, N. J., Aguiar, R. S., Pybus, O. G., Sabino, E. C., Faria, N. R.
10.1101/2020.06.11.20128249 — Posted: 2020-06-12
Temporal clinical and laboratory response to interleukin-6 receptor blockade with Tocilizumab in 89 hospitalized patients with COVID-19 pneumonia
Formina, D. S., Lysenko, M. A., Beloglazova, I. P., Mutinova, z. Y., Poteshkina, N. G., Samsonova, I. V., Kruglova, T. S., Chernov, A. A., Karaulov, A. V., Lederman, M. M.
10.1101/2020.06.12.20122374 — Posted: 2020-06-12
Sensitivity of commercial Anti-SARS-CoV-2 serological assays in a high-prevalence setting
Mueller, L., Ostermann, P. N., Walker, A., Wienemann, T., Mertens, A., Adams, O., Andree, M., Hauka, S., Keitel, V., Drexler, I., Di Cristanziano, V., Hermsen, D. F., Kaiser, R., Boege, F., Klein, F., Schaal, H., Timm, J., Senff, T.
10.1101/2020.06.11.20128686 — Posted: 2020-06-12 Discussion: Onsite
Emotional health concerns of oncology physicians in the United States: fallout during the COVID-19 pandemic
Thomaier, L., Teoh, D., Jewett, P., Beckwith, H., Parsons, H., Yuan, J., Blaes, A. H., Lou, E., Hui, J. Y. C., Vogel, R. I.
10.1101/2020.06.11.20128702 — Posted: 2020-06-12
Coronavirus and birth in Italy: results of a national population-based cohort study
Maraschini, A., Corsi, E., Salvatore, M. A., Donati, S.
10.1101/2020.06.11.20128652 — Posted: 2020-06-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).